{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:48:39Z","timestamp":1778039319467,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.mehy.2021.110685","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T02:35:55Z","timestamp":1632191755000},"page":"110685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Transient Receptor Potential Vanilloid 1 (TRPV1) as a plausible novel therapeutic target for treating neurological complications in ZikaVirus"],"prefix":"10.1016","volume":"156","author":[{"given":"Ranjana","family":"Bhandari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reetrakshi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anushka","family":"Vashishth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Kuhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2021.110685_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-016-0551-1","article-title":"Nucleotide composition of the Zika virus RNA genome and its codon usage","volume":"13","author":"Van Hemert","year":"2016","journal-title":"Virol J"},{"key":"10.1016\/j.mehy.2021.110685_b0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jamaneurol.2016.0800","article-title":"Zika virus as an emerging global pathogen: Neurological complications of zika virus","volume":"73","author":"Beckham","year":"2016","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.mehy.2021.110685_b0015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","article-title":"A Mouse Model of Zika Virus Pathogenesis","volume":"19","author":"Lazear","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mehy.2021.110685_b0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5603\/IMH.2016.0033","article-title":"Prevention of sexual transmission of Zika virus","volume":"67","author":"Kuna","year":"2016","journal-title":"Int Marit Health"},{"key":"10.1016\/j.mehy.2021.110685_b0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2017.03.001","article-title":"Zika virus: History, epidemiology, transmission, and clinical presentation","volume":"308","author":"Song","year":"2017","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.mehy.2021.110685_b0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2471\/BLT.16.171082","article-title":"Zika: the origin and spread of a mosquito-borne virus","volume":"94","author":"Kindhauser","year":"2016","journal-title":"Bull TheWorld Heal Organ"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/S0103-73312016000100002","article-title":"Zika and Microcephaly: can we learn from history?","volume":"26","author":"L\u00f6wy","year":"2016","journal-title":"Physis Rev Sa\u00fade Coletiva"},{"key":"10.1016\/j.mehy.2021.110685_b0040","doi-asserted-by":"crossref","first-page":"S860","DOI":"10.1093\/infdis\/jix451","article-title":"History and Emergence of Zika Virus","volume":"216","author":"Gubler","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2021.110685_b0045","unstructured":"World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus. 2018:16\u20138."},{"issue":"10107","key":"10.1016\/j.mehy.2021.110685_b0050","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(17)31450-2","article-title":"An update on Zika virus infection","volume":"390","author":"Baud","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2021.110685_b0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13104-019-4371-4","article-title":"Serological evidence of Zika virus infection in febrile patients at Greater Accra Regional Hospital","volume":"12","author":"Ankrah","year":"2019","journal-title":"Accra Ghana. BMC Res Notes"},{"key":"10.1016\/j.mehy.2021.110685_b0060","unstructured":"WHO. Zika virus 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/zika-virus (accessed March 13, 2021)."},{"issue":"11-12","key":"10.1016\/j.mehy.2021.110685_b0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.micinf.2018.02.009","article-title":"Zika virus: from an obscurity to a priority","volume":"20","author":"Lee","year":"2018","journal-title":"Microbes Infect"},{"issue":"2","key":"10.1016\/j.mehy.2021.110685_b0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mjafi.2016.02.017","article-title":"Dengue, chikungunya and the missing entity \u2013 Zika fever: A new emerging threat","volume":"72","author":"Tilak","year":"2016","journal-title":"Med J Armed Forces India"},{"issue":"2","key":"10.1016\/j.mehy.2021.110685_b0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bjid.2018.02.005","article-title":"Prevalence of Guillain-Barr\u00e9 syndrome among Zika virus infected cases: a systematic review and meta-analysis","volume":"22","author":"Barbi","year":"2018","journal-title":"Brazilian J Infect Dis"},{"issue":"11","key":"10.1016\/j.mehy.2021.110685_b0080","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3390\/ijerph17113806","article-title":"Zika virus and the risk of developing microcephaly in infants: A systematic review","volume":"17","author":"Antoniou","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.mehy.2021.110685_b0085","unstructured":"WHO | Microcephaly n.d. https:\/\/www.who.int\/maternal_child_adolescent\/topics\/newborn\/microcephaly\/en\/ (accessed December 15, 2020)."},{"key":"10.1016\/j.mehy.2021.110685_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-46389-0","article-title":"Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus","volume":"9","author":"Dhiman","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2021.110685_b0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bbi.2017.03.007","article-title":"Modulation of neuroinflammation: Role and therapeutic potential of TRPV1 in the neuro-immune axis","volume":"64","author":"Kong","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2021.110685_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.01087","article-title":"Inflammation, Cancer and Immunity\u2014Implication of TRPV1 Channel","volume":"9","author":"Bujak","year":"2019","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.mehy.2021.110685_b0105","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1111\/bph.12615","article-title":"Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation","volume":"171","author":"Hassan","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2021.110685_b0110","article-title":"TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0115","article-title":"Transient receptor potential ankyrin 1 (trpa1) mediates il-1\u03b2-induced apoptosis in rat chondrocytes via calcium overload and mitochondrial dysfunction","volume":"15","author":"Yin","year":"2018","journal-title":"J Inflamm (United Kingdom)"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-030212-183811","article-title":"TRPA1: A gatekeeper for inflammation","volume":"75","author":"Bautista","year":"2013","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"10.1016\/j.mehy.2021.110685_b0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s13365-018-0614-8","article-title":"Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options","volume":"24","author":"Koppolu","year":"2018","journal-title":"J Neurovirol"},{"key":"10.1016\/j.mehy.2021.110685_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2017.08.001","article-title":"Current status of therapeutic and vaccine approaches against Zika virus","volume":"44","author":"Wahid","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.mehy.2021.110685_b0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/epi.16444","article-title":"Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response","volume":"61","author":"Carvalho","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.mehy.2021.110685_b0140","doi-asserted-by":"crossref","unstructured":"Rapha\u00ebl JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev 2001:CD001798. Doi: 10.1002\/14651858.CD001798.","DOI":"10.1002\/14651858.CD001798"},{"key":"10.1016\/j.mehy.2021.110685_b0145","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1684\/ecn.2019.0433","article-title":"Zika virus in the eye of the cytokine storm","volume":"30","author":"Maucourant","year":"2019","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"10.1016\/j.mehy.2021.110685_b0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2007.07.010","article-title":"The cytokine TNF\u03b1 increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation","volume":"36","author":"Hensellek","year":"2007","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.mehy.2021.110685_b0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3947\/ic.2017.49.2.91","article-title":"An update on Zika virus in Asia","volume":"49","author":"Lim","year":"2017","journal-title":"Infect Chemother"},{"key":"10.1016\/j.mehy.2021.110685_b0160","doi-asserted-by":"crossref","unstructured":"Lum FM, Low DKS, Fan Y, Tan JJL, Lee B, Chan JKY, et al. Zika virus infects human fetal brain microglia and induces inflammation. Clin Infect Dis 2017;64:914\u201320. Doi: 10.1093\/cid\/ciw878.","DOI":"10.1093\/cid\/ciw878"},{"key":"10.1016\/j.mehy.2021.110685_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01928","article-title":"The transcriptional and protein profile from human infected neuroprogenitor cells is strongly correlated to zika virus microcephaly cytokines phenotype evidencing a persistent inflammation in the CNS","volume":"10","author":"Lima","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2021.110685_b0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007074420772","article-title":"Inflammatory mediators and modulation of blood-brain barrier permeability","volume":"20","author":"Nj","year":"2000","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49796-5","article-title":"Inflammation markers in the saliva of infants born from Zika-infected mothers: exploring potential mechanisms of microcephaly during fetal development","volume":"9","author":"de Oliveira","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.mehy.2021.110685_b0180","doi-asserted-by":"crossref","first-page":"18362","DOI":"10.3390\/ijms151018362","article-title":"TRPV1 activation exacerbates hypoxia\/reoxygenation-induced apoptosis in H9C2 cells via calcium overload and mitochondrial dysfunction","volume":"15","author":"Sun","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.mehy.2021.110685_b0185","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/cdd.2008.78","article-title":"Bid-induced release of AIF from mitochondria causes immediate neuronal cell death","volume":"15","author":"Landshamer","year":"2008","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0166-2236(99)01479-4","article-title":"Calpain and caspase: Can you tell the difference?","volume":"23","author":"Wang","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2021.110685_b0195","doi-asserted-by":"crossref","unstructured":"Yao S, Chen H, Zhang Q, Shi Z, Liu J, Lian Z, et al. Pain during the acute phase of Guillain-Barr\u00e9 syndrome. Med (United States) 2018;97:1\u20135. Doi: 10.1097\/MD.0000000000011595.","DOI":"10.1097\/MD.0000000000011595"},{"issue":"10027","key":"10.1016\/j.mehy.2021.110685_b0200","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: A case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.mehy.2021.110685_b0205","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","article-title":"Guillain-Barr\u00e9 Syndrome Associated with Zika Virus Infection in Colombia","volume":"375","author":"Parra","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2021.110685_b0210","doi-asserted-by":"crossref","unstructured":"Roz\u00e9 B, Najioullah F, Ferg\u00e9 JL, Dorl\u00e9ans F, Apetse K, Barnay JL, et al. Guillain-Barr\u00e9 Syndrome Associated with Zika Virus Infection in Martinique in 2016: A Prospective Study. Clin Infect Dis 2017;65:1462\u20138. Doi: 10.1093\/cid\/cix588.","DOI":"10.1093\/cid\/cix588"},{"issue":"4","key":"10.1016\/j.mehy.2021.110685_b0215","doi-asserted-by":"crossref","first-page":"e0008264","DOI":"10.1371\/journal.pntd.0008264","article-title":"Guillain-Barr\u00e9 syndrome related to Zika virus infection: A systematic review and meta-analysis of the clinical and electrophysiological phenotype","volume":"14","author":"Leonhard","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.mehy.2021.110685_b0220","first-page":"433","article-title":"Pain management in Guillain-Barre syndrome: A systematic review","volume":"30","author":"Pe\u00f1a","year":"2015","journal-title":"Neurol English Ed"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrd2757","article-title":"Transient receptor potential channels: Targeting pain at the source","volume":"8","author":"Patapoutian","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0230","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01821-5","article-title":"Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells","volume":"17","author":"Gr\u00fcter","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0235","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jep.2011.11.005","article-title":"Antioxidant and anti-inflammatory properties of Capsicum baccatum: From traditional use to scientific approach","volume":"139","author":"Zimmer","year":"2012","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0240","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2007.07.039","article-title":"Functional changes in the vanilloid receptor subtype 1 channel during and after acute desensitization","volume":"149","author":"Novakova-Tousova","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2021.110685_b0245","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1172\/JCI20449","article-title":"Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control","volume":"113","author":"Karai","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2021.110685_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9562.1000114","article-title":"Distribution of TRPV1 in CSF Contacting Nucleus of Rat Brain Parenchyma and its expression in Neuropathic Pain","volume":"2","author":"Xu","year":"2011","journal-title":"J Neurol Neurophysiol"},{"key":"10.1016\/j.mehy.2021.110685_b0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1744-8069-6-66","article-title":"Moving towards supraspinal TRPV1 receptors for chronic pain relief","volume":"6","author":"Palazzo","year":"2010","journal-title":"Mol Pain"},{"issue":"6","key":"10.1016\/j.mehy.2021.110685_b0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10787-016-0288-x","article-title":"TRP channels: potential drug target for neuropathic pain","volume":"24","author":"Marwaha","year":"2016","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.mehy.2021.110685_b0265","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.2174\/156802611796904825","article-title":"TRPV1 Activation is Not An All-Or-None Event: TRPV1 Partial Agonism\/Antagonism and Its Regulatory Modulation","volume":"11","author":"Blumberg","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.mehy.2021.110685_b0270","unstructured":"Pain Thresholds Under High-dose Topical Capsaicin - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02570841?term=Capsaicin&draw=2&rank=8 (accessed December 31, 2020)."},{"issue":"8","key":"10.1016\/j.mehy.2021.110685_b0275","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1089\/jpm.2012.9571","article-title":"Topical capsaicin for neuropathic pain #255","volume":"15","author":"Groninger","year":"2012","journal-title":"J Palliat Med"},{"issue":"23","key":"10.1016\/j.mehy.2021.110685_b0280","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/0024-3205(92)90045-Q","article-title":"Mechanism of action of capsaicin-like molecules on sensory neurons","volume":"51","author":"Dray","year":"1992","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2021.110685_b0285","unstructured":"Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04572776?term=NCT04572776&draw=1&rank=1 (accessed December 31, 2020)."},{"issue":"10","key":"10.1016\/j.mehy.2021.110685_b0290","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1432-1033.2004.04083.x","article-title":"Molecular architecture of the vanilloid receptor: Insights for drug design","volume":"271","author":"Ferrer-Montiel","year":"2004","journal-title":"Eur J Biochem"},{"issue":"1","key":"10.1016\/j.mehy.2021.110685_b0295","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/19336950.2019.1654347","article-title":"Myrcene and terpene regulation of TRPV1","volume":"13","author":"Jansen","year":"2019","journal-title":"Channels"},{"key":"10.1016\/j.mehy.2021.110685_b0300","unstructured":"Analgesic and Subjective Effects of Terpenes - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04451863?term=Myrcene&cond=Pain&draw=2&rank=1 (accessed December 31, 2020)."},{"key":"10.1016\/j.mehy.2021.110685_b0305","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0706040","article-title":"Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1)","volume":"144","author":"McNamara","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2021.110685_b0310","unstructured":"Curcumin and Piperine in Reducing Inflammation for Ureteral Stent-Induced Symptoms in Patients With Cancer - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02598726?term=NCT02598726&draw=2&rank=1 (accessed December 31, 2020)."},{"issue":"36","key":"10.1016\/j.mehy.2021.110685_b0315","doi-asserted-by":"crossref","first-page":"31405","DOI":"10.1074\/jbc.M501489200","article-title":"Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system","volume":"280","author":"H\u00f6gest\u00e4tt","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2021.110685_b0320","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/pm\/pnz037","article-title":"Paracetamol and Pain Modulation by TRPV1, UGT2B15, SULT1A1 Genotypes: A Randomized Clinical Trial in Healthy Volunteers","volume":"21","author":"Pickering","year":"2020","journal-title":"Pain Med"},{"issue":"12","key":"10.1016\/j.mehy.2021.110685_b0325","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","article-title":"An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors","volume":"99","author":"Huang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mehy.2021.110685_b0330","unstructured":"Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03397212?term=NADA&cond=Pain&draw=2&rank=1 (accessed December 31, 2020)."},{"key":"10.1016\/j.mehy.2021.110685_b0335","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1523\/JNEUROSCI.1246-06.2006","article-title":"TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists","volume":"26","author":"Cui","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2021.110685_b0340","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/cells3020517","article-title":"TRPV1: A Potential Drug Target for Treating Various Diseases","volume":"3","author":"Brito","year":"2014","journal-title":"Cells"},{"key":"10.1016\/j.mehy.2021.110685_b0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157015908783769644","article-title":"Herbal Compounds and Toxins Modulating TRP Channels","volume":"6","author":"Vennekens","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.mehy.2021.110685_b0350","unstructured":"Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01056029?term=thapsigargin&draw=2&rank=1 (accessed December 31, 2020)."},{"key":"10.1016\/j.mehy.2021.110685_b0355","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/157015908784533888","article-title":"TRPV1: A Target for Next Generation Analgesics","volume":"6","author":"Premkumar","year":"2008","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"10.1016\/j.mehy.2021.110685_b0360","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.bmcl.2006.03.030","article-title":"Discovery of SB-705498: A potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development","volume":"16","author":"Rami","year":"2006","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.mehy.2021.110685_b0365","unstructured":"A Study to Investigate the Effect of SB-705498 on Chronic Cough - Full Text View - ClinicalTrials.gov n.d. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01476098?term=SB-705498&draw=2&rank=1 (accessed December 31, 2020)."},{"key":"10.1016\/j.mehy.2021.110685_b0370","unstructured":"Use Of SB-705498 In The Acute Treatment Of Migraine - Full Text View - ClinicalTrials.gov n.d. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00269022?term=SB-705498&draw=2&rank=4 (accessed December 31, 2020)."},{"key":"10.1016\/j.mehy.2021.110685_b0375","unstructured":"A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy - Full Text View - ClinicalTrials.gov n.d. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00000842?term=nerve+growth+factor&draw=2&rank=10 (accessed December 31, 2020)."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721002048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721002048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:25:30Z","timestamp":1759692330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987721002048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":75,"alternative-id":["S0306987721002048"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110685","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient Receptor Potential Vanilloid 1 (TRPV1) as a plausible novel therapeutic target for treating neurological complications in ZikaVirus","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110685"}}